Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Distribution Industry Remained Efficient and Resilient During First Year of COVID-19
Data released by the Healthcare Distribution Alliance (HDA) Research Foundation indicate that despite the challenges of COVID-19, pharmaceutical distributors maintained efficiencies to deliver millions of vaccines and medicines to providers — and ultimately patients. Published today, the 92nd Edition HDA Factbook: The Facts, Figures & Trends in Healthcare provides benchmarks and trends for the U.S. pharmaceutical supply chain.
HDA Factbook: Rx Sales Through Traditional Healthcare Distributors Increase
New data released by the HDA Research Foundation reveal that total prescription sales through traditional pharmaceutical distribution jumped 15.5 percent in 2022 to reach $666 billion. As highlighted in the 94th Edition HDA Factbook, an estimated 95 percent of all pharmaceutical sales move through the traditional distribution channel. Moreover, distributors are operating on the lowest margins in the study’s history — in 2022, the industry’s net profit margin after taxes was 0.4 percent.
Rx Sales Through HDA Healthcare Distributors Remained Strong in 2021, Accounting for 94 Percent of Overall Market
According to the HDA Research Foundation, approximately 94 percent of pharmaceutical sales were completed through healthcare distributors in 2021. As reported in the 93rd Edition HDA Factbook, sales through traditional healthcare distributors rose by a record-high 9.4 percent to reach $598.7 billion as the COVID-19 pandemic entered its second year.
Three Healthcare Distribution Industry Trends To Watch
For nearly a century, the HDA Factbook has reported on the productivity behind the safe and effective delivery of millions of medicines and healthcare products nationwide. Published by the HDA Research Foundation, the latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings. A recent LinkedIn Live discussion provided additional perspective into the trends shaping the pharmaceutical distribution industry amid an evolving business environment.